Cite
HARVARD Citation
Wang, T. et al. (2023). Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial. Journal of clinical oncology. 41 (9), pp. 1670-1683. [Online].